🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and tolerability of ne...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center
Start Date
2021-05-28
Trial ID
NCT04658147
Treatments Being Tested
This is a Phase 1B study assessing the safety of immune checkpoint inhibiti...
Status
Active Not Recruiting
Location
Johns Hopkins University
Start Date
2019-03-06
Trial ID
NCT03610711
Treatments Being Tested
In this Phase II trial of personalized immunotherapy in R/M HNSCC, gene exp...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-05-14
Trial ID
NCT04326257
Treatments Being Tested
Anti-PD-1 (nivolumab) or Anti-PD1/Anti LAG-3- (relaltimab) administration i...
Status
Active Not Recruiting
Location
Johns Hopkins University
Start Date
2017-07-11
Trial ID
NCT03044613
Treatments Being Tested
The purpose of this study is to demonstrate the safety and preliminary acti...
Status
Completed
Location
Local Institution - 0006
Start Date
2018-05-30
Trial ID
NCT03459222
Treatments Being Tested
The purpose of this study is to determine if neoadjuvant (treatment before ...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2024-05-17
Trial ID
NCT06295159
Treatments Being Tested
This is a randomized, open-label, phase Ib study to assess safety and effic...
Status
Recruiting
Location
Yale University
Start Date
2025-12-29
Trial ID
NCT06963905
Treatments Being Tested
The goal of this clinical trial is to test neoadjuvant dual immunotherapy i...
Status
Recruiting
Location
Melanoma Institute Australia
Start Date
2024-03-11
Trial ID
NCT06151236
Treatments Being Tested
The NESCIO-trial is a multicenter, randomized, open-label, three-arm phase ...
Status
Active Not Recruiting
Location
Netherlands Cancer Institute
Start Date
2022-04-28
Trial ID
NCT05148546
Treatments Being Tested
The primary objective of this study is to characterize the safety, tolerabi...
Status
Completed
Location
Local Institution - 0007
Start Date
2014-03-13
Trial ID
NCT02061761
Treatments Being Tested